Cargando…

Host immune responses during Taenia solium Neurocysticercosis infection and treatment

Taenia solium cysticercosis and taeniasis (TSCT), caused by the tapeworm T. solium, is a foodborne and zoonotic disease classified since 2010 by WHO as a neglected tropical isease. It causes considerable impact on health and economy and is one of the leading causes of acquired epilepsy in most endem...

Descripción completa

Detalles Bibliográficos
Autores principales: Prodjinotho, Ulrich Fabien, Lema, Jakobo, Lacorcia, Matthew, Schmidt, Veronika, Vejzagic, Nermina, Sikasunge, Chummy, Ngowi, Bernard, Winkler, Andrea Sylvia, Prazeres da Costa, Clarissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162612/
https://www.ncbi.nlm.nih.gov/pubmed/32298263
http://dx.doi.org/10.1371/journal.pntd.0008005
_version_ 1783523064022040576
author Prodjinotho, Ulrich Fabien
Lema, Jakobo
Lacorcia, Matthew
Schmidt, Veronika
Vejzagic, Nermina
Sikasunge, Chummy
Ngowi, Bernard
Winkler, Andrea Sylvia
Prazeres da Costa, Clarissa
author_facet Prodjinotho, Ulrich Fabien
Lema, Jakobo
Lacorcia, Matthew
Schmidt, Veronika
Vejzagic, Nermina
Sikasunge, Chummy
Ngowi, Bernard
Winkler, Andrea Sylvia
Prazeres da Costa, Clarissa
author_sort Prodjinotho, Ulrich Fabien
collection PubMed
description Taenia solium cysticercosis and taeniasis (TSCT), caused by the tapeworm T. solium, is a foodborne and zoonotic disease classified since 2010 by WHO as a neglected tropical isease. It causes considerable impact on health and economy and is one of the leading causes of acquired epilepsy in most endemic countries of Latin America, Sub-Saharan Africa, and Asia. There is some evidence that the prevalence of TSCT in high-income countries has recently increased, mainly due to immigration from endemic areas. In regions endemic for TSCT, human cysticercosis can manifest clinically as neurocysticercosis (NCC), resulting in epileptic seizures and severe progressive headaches, amongst other neurological signs and/or symptoms. The development of these symptoms results from a complex interplay between anatomical cyst localization, environmental factors, parasite’s infective potential, host genetics, and, especially, host immune responses. Treatment of individuals with active NCC (presence of viable cerebral cysts) with anthelmintic drugs together with steroids is usually effective and, in the majority, reduces the number and/or size of cerebral lesions as well as the neurological symptoms. However, in some cases, treatment may profoundly enhance anthelmintic inflammatory responses with ensuing symptoms, which, otherwise, would have remained silent as long as the cysts are viable. This intriguing silencing process is not yet fully understood but may involve active modulation of host responses by cyst-derived immunomodulatory components released directly into the surrounding brain tissue or by the induction of regulatory networks including regulatory T cells (Treg) or regulatory B cells (Breg). These processes might be disturbed once the cysts undergo treatment-induced apoptosis and necrosis or in a coinfection setting such as HIV. Herein, we review the current literature regarding the immunology and pathogenesis of NCC with a highlight on the mobilization of immune cells during human NCC and their interaction with viable and degenerating cysticerci. Moreover, the immunological parameters associated with NCC in people living with HIV/AIDS and treatments are discussed. Eventually, we propose open questions to understand the role of the immune system and its impact in this intriguing host–parasite crosstalk.
format Online
Article
Text
id pubmed-7162612
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71626122020-04-22 Host immune responses during Taenia solium Neurocysticercosis infection and treatment Prodjinotho, Ulrich Fabien Lema, Jakobo Lacorcia, Matthew Schmidt, Veronika Vejzagic, Nermina Sikasunge, Chummy Ngowi, Bernard Winkler, Andrea Sylvia Prazeres da Costa, Clarissa PLoS Negl Trop Dis Review Taenia solium cysticercosis and taeniasis (TSCT), caused by the tapeworm T. solium, is a foodborne and zoonotic disease classified since 2010 by WHO as a neglected tropical isease. It causes considerable impact on health and economy and is one of the leading causes of acquired epilepsy in most endemic countries of Latin America, Sub-Saharan Africa, and Asia. There is some evidence that the prevalence of TSCT in high-income countries has recently increased, mainly due to immigration from endemic areas. In regions endemic for TSCT, human cysticercosis can manifest clinically as neurocysticercosis (NCC), resulting in epileptic seizures and severe progressive headaches, amongst other neurological signs and/or symptoms. The development of these symptoms results from a complex interplay between anatomical cyst localization, environmental factors, parasite’s infective potential, host genetics, and, especially, host immune responses. Treatment of individuals with active NCC (presence of viable cerebral cysts) with anthelmintic drugs together with steroids is usually effective and, in the majority, reduces the number and/or size of cerebral lesions as well as the neurological symptoms. However, in some cases, treatment may profoundly enhance anthelmintic inflammatory responses with ensuing symptoms, which, otherwise, would have remained silent as long as the cysts are viable. This intriguing silencing process is not yet fully understood but may involve active modulation of host responses by cyst-derived immunomodulatory components released directly into the surrounding brain tissue or by the induction of regulatory networks including regulatory T cells (Treg) or regulatory B cells (Breg). These processes might be disturbed once the cysts undergo treatment-induced apoptosis and necrosis or in a coinfection setting such as HIV. Herein, we review the current literature regarding the immunology and pathogenesis of NCC with a highlight on the mobilization of immune cells during human NCC and their interaction with viable and degenerating cysticerci. Moreover, the immunological parameters associated with NCC in people living with HIV/AIDS and treatments are discussed. Eventually, we propose open questions to understand the role of the immune system and its impact in this intriguing host–parasite crosstalk. Public Library of Science 2020-04-16 /pmc/articles/PMC7162612/ /pubmed/32298263 http://dx.doi.org/10.1371/journal.pntd.0008005 Text en © 2020 Prodjinotho et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Prodjinotho, Ulrich Fabien
Lema, Jakobo
Lacorcia, Matthew
Schmidt, Veronika
Vejzagic, Nermina
Sikasunge, Chummy
Ngowi, Bernard
Winkler, Andrea Sylvia
Prazeres da Costa, Clarissa
Host immune responses during Taenia solium Neurocysticercosis infection and treatment
title Host immune responses during Taenia solium Neurocysticercosis infection and treatment
title_full Host immune responses during Taenia solium Neurocysticercosis infection and treatment
title_fullStr Host immune responses during Taenia solium Neurocysticercosis infection and treatment
title_full_unstemmed Host immune responses during Taenia solium Neurocysticercosis infection and treatment
title_short Host immune responses during Taenia solium Neurocysticercosis infection and treatment
title_sort host immune responses during taenia solium neurocysticercosis infection and treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162612/
https://www.ncbi.nlm.nih.gov/pubmed/32298263
http://dx.doi.org/10.1371/journal.pntd.0008005
work_keys_str_mv AT prodjinothoulrichfabien hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT lemajakobo hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT lacorciamatthew hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT schmidtveronika hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT vejzagicnermina hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT sikasungechummy hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT ngowibernard hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT winklerandreasylvia hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment
AT prazeresdacostaclarissa hostimmuneresponsesduringtaeniasoliumneurocysticercosisinfectionandtreatment